MSLN and ovarian carcinoma: Heterotypic (cancer cell to mesothelial cell) interactions of mesothelin (MSLN) and its binding partner MUC16, which is the membrane-bound form of the ovarian cancer serum tumor marker CA-125 [104] are important for attachment of cancer cells to the mesothelial layer [174].